Study shows AI-assisted risk model for lung nodules is cost-effective
Study shows AI-assisted risk model for lung nodules is cost-effective
Publish Date: 2026-03-20 12:41:00
Source Domain: news.vumc.org
- Lung screenings using low-dose CT scans are crucial for early cancer detection but cannot determine if pulmonary nodules are cancerous or benign.
- Radiologists, pulmonologists, and surgeons analyze imaging to decide if invasive biopsies are needed, a process known as risk stratification of pulmonary nodules.
- About a tenth to a fifteenth of surgeries for these nodules are for benign tissue, hence risk prediction software such as the Lung Cancer Prediction Score aids in necessity determination.
- Artificial intelligence-assisted decision-making using such software results in being cost-effective compared to clinician assessment alone, with a cost-effective ratio of $4,485 per life year gained per a study.
- The study by Vanderbilt Health emphasized the cost-effectiveness of AI-assisted decision-making for managing indeterminate pulmonary nodules.
